CD4 and type 2 diabetes mellitus: There is evidence from animal models and human studies that functional changes and alterations in the cytokine profiles produced by these cells, especially by the specific pro-inflammatory T helper 1 (Th1) subset of CD4+ T cells, are associated with the pathogenesis of T2D (2,4).